April 15, 2020
RAMM Pharma Corp. (CSE:RAMM)announces its intention to commence a normal course issuer bid, under which it may purchase up to...
March 30, 2020
RAMM Pharma announces that it will not be filing its interim financial statements for the quarter ended January 31, 2020.
March 26, 2020
RAMM Pharma (CSE:RAMM)is pleased to announce that the Uruguayan Ministry of Public Health has approved and registered XALEX™ 10 (cannabidiol)...
March 23, 2020
RAMM Pharma Corp. (CSE: RAMM) provided a corporate update and information regarding the Company’s ongoing support of the medical community’s...
February 25, 2020
RAMM Pharma Corp. has entered into a definitive agreement dated February 24, 2020 to acquire Glediser S.A. operating as NettaLife™
November 8, 2019
RAMM Pharma (CSE:RAMM) begins trading on the Canadian Securities Exchange today under the ticker symbol “RAMM”.
October 29, 2019
RAMM Pharma Corp. (CSE:RAMM) is pleased to announce that on October 28, 2019 it completed its previously announced business combination...